Drugs, patents and policy : a contextual study of Hong Kong / Bryan Mercurio (The Chinese University of Hong Kong).
2018
HD9665.6 .M47 2018 (Map It)
Available at Cellar
Formats
Format | |
---|---|
BibTeX | |
MARCXML | |
TextMARC | |
MARC | |
DublinCore | |
EndNote | |
NLM | |
RefWorks | |
RIS |
Items
Details
Author
Title
Drugs, patents and policy : a contextual study of Hong Kong / Bryan Mercurio (The Chinese University of Hong Kong).
Published
Cambridge, United Kingdom : Cambridge University Press, 2018.
Call Number
HD9665.6 .M47 2018
ISBN
9781316512340 (hardback)
1316512347
1316512347
Description
xvii, 221 pages ; 24 cm
System Control No.
(OCoLC)1014436586
Summary
"In pharmaceutical patent law, the problem of lack of policy direction and inappropriate legal framework is widespread - particularly among jurisdictions with little to no pharmaceutical research or manufacturing. This book aims to inform public policy and influence debate through a comprehensive review of Hong Kong's pharmaceutical patent law. By demonstrating the need for a holistic review of pharmaceutical patent laws and evaluating Hong Kong's system in light of health policy, economic and social factors, Bryan Mercurio recommends changes to the legal framework and constructs a more efficient and effective system for Hong Kong. He thoroughly evaluates the international framework and best practice models to offer a global perspective to each issue before providing local context in the analysis. While the focus of the book is Hong Kong, the analysis on pharmaceutical patent law and policy extends to other jurisdictions facing issues on reforming their national system.
Bibliography, etc. Note
Includes bibliographical references and index.
Record Appears in
Table of Contents
Foreword / Antony Taubman
ix
Acknowledgments
xiv
List of Abbreviations
xvi
1.
Introduction
1
2.
Contextual Framework of Hong Kong's Pharmaceutical Patent Laws and Policy
16
3.
Standards of Patentability
44
4.
Extension of Patent Term for Pharmaceutical Products
89
5.
Exceptions to Exclusive Rights
111
6.
Test Data Exclusivity
157
7.
Patent Linkage
183
8.
Conclusion
210
Index
215